--- title: "Avalyn Pharma Director Robert J. Meyer files initial beneficial ownership statement" type: "News" locale: "en" url: "https://longbridge.com/en/news/299360082.md" description: "Avalyn Pharma director Robert J. Meyer filed an initial Form 3 beneficial ownership statement dated September 15, 2026. The information was published via EDGAR on September 17, 2026." datetime: "2026-09-17T20:06:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299360082.md) - [en](https://longbridge.com/en/news/299360082.md) - [zh-HK](https://longbridge.com/zh-HK/news/299360082.md) generator: "portal-rs" --- # Avalyn Pharma Director Robert J. Meyer files initial beneficial ownership statement - Avalyn Pharma director Robert J. Meyer filed an initial Form 3 beneficial ownership statement dated Sept. 15, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalyn Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-394320), on September 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [AVLN.US](https://longbridge.com/en/quote/AVLN.US.md) ## Related News & Research - [Avalyn Pharma 3Q 2026: EPS ($0.67) — 10-Q Summary](https://longbridge.com/en/news/305321931.md) - [AVLN: AP03 entered Phase 1; $386.6M in cash supports a projected runway into 2029](https://longbridge.com/en/news/305321027.md) - [SoftBank Group Publishes Arm Fireside Chat Transcript](https://longbridge.com/en/news/305424159.md) - [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md) - [Almonty Management Commentary: Higher Tungsten Prices Drive Q3 2026 Revenue Growth of 382%](https://longbridge.com/en/news/305413238.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**